Financhill
Sell
4

TRKYY Quote, Financials, Valuation and Earnings

Last price:
$1.80
Seasonality move :
-5.12%
Day range:
$1.80 - $1.80
52-week range:
$1.80 - $1.80
Dividend yield:
0%
P/E ratio:
1.51x
P/S ratio:
0.51x
P/B ratio:
0.49x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$504M
Revenue:
$938.6M
EPS (TTM):
$1.19

Analysts' Opinion

  • Consensus Rating
    No consensus rating exists at this time due to lack of analyst coverage.
  • Price Target Downside
    No price target exists because of limited analyst coverage.
  • Price Target Upside
    Similarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.

Fair Value

  • According to the consensus of 0 analysts, Türkiye Sinai Kalkinma Bankasi AS has -- downside to fair value with a price target of -- per share.

TRKYY vs. S&P 500

  • Over the past 5 trading days, Türkiye Sinai Kalkinma Bankasi AS has underperformed the S&P 500 by -0.31% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Türkiye Sinai Kalkinma Bankasi AS does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Türkiye Sinai Kalkinma Bankasi AS revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Türkiye Sinai Kalkinma Bankasi AS reported revenues of $233.3M.

Earnings Growth

  • Türkiye Sinai Kalkinma Bankasi AS earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Türkiye Sinai Kalkinma Bankasi AS reported earnings per share of $0.25.
Enterprise value:
6.7B
EV / Invested capital:
0.93x
Price / LTM sales:
0.51x
EV / EBIT:
7.68x
EV / Revenue:
6.84x
PEG ratio (5yr expected):
0.09x
EV / Free cash flow:
21.72x
Price / Operating cash flow:
1.62x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
4.8%
Net Income Margin (TTM):
34.14%
Return On Equity:
35.02%
Return On Invested Capital:
4.96%
Operating Margin:
34.42%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $893.8M $952.4M $986.7M $243.4M $233.3M
Gross Profit -- -- -- -- --
Operating Income $367.2M $354.8M $397.1M $103.3M $80.3M
EBITDA -- -- -- -- --
Diluted EPS $1.07 $1.02 $1.19 $0.29 $0.25
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $624.9M $532.8M $681.5M $248.3M $571.4M
Total Assets $6.9B $5.9B $6.1B $6.6B $7.5B
Current Liabilities $18.4M $538.6M $257.7M $990.9M $959.7M
Total Liabilities $6.2B $5.4B $5.4B $5.7B $6.4B
Total Equity $757.2M $524.2M $700.2M $871.1M $1B
Total Debt $6B $4.6B $4.9B $4.5B $5.3B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations $499.7M $339.6M $314.5M -$31.5M -$85.9M
Cash From Investing -$110.2M -$873.6M -$553.9M -$256.6M -$70.6M
Cash From Financing -$20M $94.9M $593.1M $181.8M $299.1M
Free Cash Flow $495.5M $336.7M $310.7M -$33.3M -$87.6M
TRKYY
Sector
Market Cap
$504M
$553.7M
Price % of 52-Week High
100%
89.88%
Dividend Yield
0%
1.65%
Shareholder Yield
-33.94%
3.16%
1-Year Price Total Return
--
1.48%
Beta (5-Year)
0.052
0.481
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $1.80
200-day SMA
Sell
Level $1.80
Bollinger Bands (100)
Sell
Level 1.8 - 1.8
Chaikin Money Flow
Sell
Level --
20-day SMA
Sell
Level $1.80
Relative Strength Index (RSI14)
Sell
Level 0.00
ADX Line
Neutral
Level 69.04
Williams %R
Buy
Level 0
50-day SMA
Sell
Level $1.80
MACD (12, 26)
Sell
Level 0.00
25-day Aroon Oscillator
Sell
Level 0
On Balance Volume
Neutral
Level 1.6K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (0.4647)
Sell
CA Score (Annual)
Level (-1.5329)
--
Beneish M-Score (Annual)
Level (--)
Sell
Momentum Score
Level (4)
Sell
Ohlson Score
Level (2.3363)
Buy
Piotroski F Score (Annual)
Level (6)
Buy
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (4)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Türkiye Sinai Kalkinma Bankasi AS engages in the provision of corporate, investment, and advisory services. It operates through the following segments: Corporate Banking, Investment Banking, and Other. The Corporate Banking segment serves financial solutions and banking services for its medium and large-scale corporate customers. The Investment Banking segment includes portfolio management for corporate, marketable securities intermediary activities, cash flow management, and all types of corporate finance services. The company was founded on May 12, 1950 and is headquartered in Istanbul, Turkey.

Stock Forecast FAQ

In the current month, TRKYY has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The TRKYY average analyst price target in the past 3 months is --.

  • Where Will Türkiye Sinai Kalkinma Bankasi AS Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Türkiye Sinai Kalkinma Bankasi AS share price will drop to -- per share over the next 12 months.

  • What Do Analysts Say About Türkiye Sinai Kalkinma Bankasi AS?

    Analysts are divided on their view about Türkiye Sinai Kalkinma Bankasi AS share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Türkiye Sinai Kalkinma Bankasi AS is a Sell and believe this share price will rise from its current level to --.

  • What Is Türkiye Sinai Kalkinma Bankasi AS's Price Target?

    The price target for Türkiye Sinai Kalkinma Bankasi AS over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.

  • Is TRKYY A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Türkiye Sinai Kalkinma Bankasi AS is a --. 0 of 0 analysts rate the stock a -- at this time.

  • How Can I Buy Shares Of TRKYY?

    You can purchase shares of Türkiye Sinai Kalkinma Bankasi AS via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Türkiye Sinai Kalkinma Bankasi AS shares.

  • What Is The Türkiye Sinai Kalkinma Bankasi AS Share Price Today?

    Türkiye Sinai Kalkinma Bankasi AS was last trading at $1.80 per share. This represents the most recent stock quote for Türkiye Sinai Kalkinma Bankasi AS. Yesterday, Türkiye Sinai Kalkinma Bankasi AS closed at $1.80 per share.

  • How To Buy Türkiye Sinai Kalkinma Bankasi AS Stock Online?

    In order to purchase Türkiye Sinai Kalkinma Bankasi AS stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Is Amazon an AI Stock?
Is Amazon an AI Stock?

With the market starting to look skittish on pure-play AI…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.4T
P/E Ratio: 62x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
81
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 40x

Alerts

Buy
56
SMX alert for Dec 8

SMX (Security Matters) Plc [SMX] is down 65.66% over the past day.

Buy
62
PRAX alert for Dec 8

Praxis Precision Medicines, Inc. [PRAX] is up 9.94% over the past day.

Sell
13
PSN alert for Dec 8

Parsons Corp. [PSN] is down 4.41% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock